{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:30:28Z","timestamp":1786480228801,"version":"build-2736575974"},"reference-count":141,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:p>Hematopoietic stem cell transplantation (HSCT) is a potentially curative therapy for patients with hematologic malignancies and certain solid tumors and nonmalignant hematologic conditions. Both AKI and CKD occur commonly after HSCT and are associated with significant morbidity and mortality. AKI and CKD in this setting may result from direct effects of the transplant or be caused by pretransplant bone marrow conditioning regimens and\/or nephrotoxic agents administered in the post-transplant period. In this article, we review the epidemiology, risk factors, etiologies, pathophysiology, diagnosis, prevention, and treatment of post-HSCT AKI and CKD, with special attention to recent advances in this fast-moving and evolving field.<\/jats:p>","DOI":"10.34067\/kid.0000000692","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T12:02:37Z","timestamp":1736424157000},"page":"317-330","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Kidney Disease and Hematopoietic Stem Cell Transplantation"],"prefix":"10.34067","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4536-9891","authenticated-orcid":false,"given":"Amanda DeMauro","family":"Renaghan","sequence":"first","affiliation":[{"name":"Division of Nephrology, University of Virginia Health System, Charlottesville, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0408-7057","authenticated-orcid":false,"given":"Jos\u00e9 Maximino","family":"Costa","sequence":"additional","affiliation":[{"name":"Nephrology Department, Instituto Portugu\u00eas de Oncologia do Porto, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8199-7716","authenticated-orcid":false,"given":"Alexandra","family":"Esteves","sequence":"additional","affiliation":[{"name":"Nephrology Department, Centro Hospitalar Universit\u00e1rio de Coimbra, Coimbra, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"issue":"3","key":"B1-20250227","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood."},{"issue":"2","key":"B2-20250227","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2215\/CJN.08580719","article-title":"Acute kidney injury and CKD associated with hematopoietic stem cell transplantation","volume":"15","author":"Renaghan","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B4-20250227","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/biomedicines5020033","article-title":"T-Cell manipulation strategies to prevent graft-versus-host disease in haploidentical stem cell transplantation","volume":"5","author":"Vadakekolathu","year":"2017","journal-title":"Biomedicines."},{"issue":"9","key":"B5-20250227","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/qjmed\/hcaa072","article-title":"Incidence and mortality of acute kidney injury in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"113","author":"Kanduri","year":"2020","journal-title":"QJM."},{"issue":"2","key":"B6-20250227","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.ackd.2021.11.003","article-title":"Kidney disease following hematopoietic stem cell transplantation","volume":"29","author":"Abudayyeh","year":"2022","journal-title":"Adv Chronic Kidney Dis."},{"issue":"6","key":"B7-20250227","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1002\/cam4.2187","article-title":"Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma","volume":"8","author":"Andronesi","year":"2019","journal-title":"Cancer Med."},{"issue":"7","key":"B8-20250227","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/ndt\/gfab189","article-title":"Predictors and outcomes of acute kidney injury during autologous stem cell transplantation in AL amyloidosis","volume":"37","author":"Nader","year":"2022","journal-title":"Nephrol Dial Transplant."},{"key":"B9-20250227","doi-asserted-by":"crossref","first-page":"1186503","DOI":"10.3389\/fonc.2023.1186503","article-title":"Acute kidney injury and chronic kidney disease in umbilical cord blood transplant recipients","volume":"13","author":"Lopedote","year":"2023","journal-title":"Front Oncol."},{"issue":"4","key":"B10-20250227","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbmt.2019.12.768","article-title":"Incidence and risk factors for acute and chronic kidney injury after adult cord blood transplantation","volume":"26","author":"Gutgarts","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"issue":"11-12","key":"B11-20250227","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1159\/000533945","article-title":"Risk factors for acute kidney injury after hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"52","author":"Cui","year":"2023","journal-title":"Blood Purif."},{"issue":"9","key":"B12-20250227","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41409-022-01720-8","article-title":"Acute kidney injury caused by haplostorm after allogenic hematopoietic stem cell transplant","volume":"57","author":"Hanna","year":"2022","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"B13-20250227","doi-asserted-by":"crossref","first-page":"ofz037","DOI":"10.1093\/ofid\/ofz037","article-title":"Infectious complications after umbilical cord blood transplantation for hematological malignancy","volume":"6","author":"Linder","year":"2019","journal-title":"Open Forum Infect Dis."},{"issue":"9","key":"B14-20250227","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.2215\/CJN.19801220","article-title":"Acute kidney injury in the modern era of allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Abramson","year":"2021","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B15-20250227","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41409-023-02136-8","article-title":"AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients","volume":"59","author":"Kim","year":"2024","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"B16-20250227","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40620-023-01809-3","article-title":"Acute kidney injury in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant: a cohort study","volume":"37","author":"Rodrigues","year":"2024","journal-title":"J Nephrol."},{"issue":"9","key":"B17-20250227","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/s41409-022-01744-0","article-title":"Acute kidney injury within 100 days post allogeneic hematopoietic cell transplantation is associated with increased risk of post-transplant complications and poor transplant outcomes","volume":"57","author":"Madsen","year":"2022","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"B18-20250227","doi-asserted-by":"crossref","first-page":"455.e1","DOI":"10.1016\/j.jtct.2023.03.029","article-title":"Clinical features of acute kidney injury in the early post-transplantation period following reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Vergara-Cadavid","year":"2023","journal-title":"Transplant Cell Ther."},{"issue":"8","key":"B19-20250227","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41409-024-02292-5","article-title":"Acute kidney injury during autologous stem cell transplantation in light chain amyloidosis with kidney involvement and their impact on prognosis","volume":"59","author":"Xu","year":"2024","journal-title":"Bone Marrow Transplant."},{"issue":"8","key":"B20-20250227","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/ckj\/sfac091","article-title":"Chronic kidney disease, survival and graft-versus-host-disease-free\/relapse-free survival in recipients of allogeneic hematopoietic stem cell transplant","volume":"15","author":"Pelletier","year":"2022","journal-title":"Clin Kidney J."},{"issue":"7","key":"B21-20250227","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B22-20250227","first-page":"e12418","article-title":"Kidney recovery from acute kidney injury after hematopoietic stem cell transplant: a systematic review and meta-analysis","volume":"13","author":"Kanduri","year":"2021","journal-title":"Cureus."},{"issue":"1","key":"B23-20250227","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.ajkd.2004.09.015","article-title":"Acute renal insufficiency after high-dose melphalan in patients with primary systemic amyloidosis during stem cell transplantation","volume":"45","author":"Leung","year":"2005","journal-title":"Am J Kidney Dis."},{"issue":"12","key":"B24-20250227","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.3109\/10428194.2014.897701","article-title":"Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant","volume":"55","author":"Petri","year":"2014","journal-title":"Leuk Lymphoma."},{"issue":"11","key":"B25-20250227","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1182\/blood.V106.11.1775.1775","article-title":"Risk factor analysis for thrombotic microangiopathy after reduced intensity or myeloablative allogeneic hematopoietic stem cell transplantation","volume":"106","author":"Nakamae","year":"2005","journal-title":"Blood."},{"issue":"6","key":"B26-20250227","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood."},{"issue":"3","key":"B27-20250227","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.transci.2007.03.004","article-title":"ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy","volume":"36","author":"Worel","year":"2007","journal-title":"Transfus Apher Sci."},{"issue":"4","key":"B28-20250227","first-page":"339","article-title":"Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?","volume":"3","author":"Chappell","year":"1988","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"B29-20250227","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJMra032401","article-title":"Acute renal failure and sepsis","volume":"351","author":"Schrier","year":"2004","journal-title":"New Engl J Med."},{"issue":"1","key":"B30-20250227","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The many faces of calcineurin inhibitor toxicity\u2014what the FK?","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv Chronic Kidney Dis."},{"issue":"3","key":"B31-20250227","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev."},{"issue":"4","key":"B32-20250227","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2215\/CJN.06470614","article-title":"Estimating GFR in adult patients with hematopoietic cell transplant: comparison of estimating equations with an iohexol reference standard","volume":"10","author":"Hingorani","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"B33-20250227","doi-asserted-by":"crossref","first-page":"c187","DOI":"10.1159\/000328911","article-title":"Trimethoprim, creatinine and creatinine-based equations","volume":"119","author":"Delanaye","year":"2011","journal-title":"Nephron Clin Pract."},{"issue":"4","key":"B34-20250227","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.transproceed.2022.02.040","article-title":"Increase urinary biomarkers of kidney injury in patients after allogenic hematopoietic stem cell transplant reflect kidney damage even in normal kidney function","volume":"54","author":"K\u0119pska-Dzili\u0144ska","year":"2022","journal-title":"Transplant Proc."},{"issue":"8","key":"B35-20250227","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2215\/CJN.0000000000000508","article-title":"Assessment of GFR in patients with cancer: a statement from the American Society of Onco-Nephrology","volume":"19","author":"Kitchlu","year":"2024","journal-title":"Clin J Am Soc Nephrol."},{"key":"B36-20250227","doi-asserted-by":"crossref","first-page":"779881","DOI":"10.3389\/fimmu.2021.779881","article-title":"Recent advances of acute kidney injury in hematopoietic cell transplantation","volume":"12","author":"Miyata","year":"2021","journal-title":"Front Immunol."},{"issue":"3","key":"B37-20250227","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jmii.2021.01.001","article-title":"Cytomegalovirus management after allogeneic hematopoietic stem cell transplantation: a mini-review","volume":"54","author":"Jerry Teng","year":"2021","journal-title":"J Microbiol Immunol Infect."},{"issue":"5","key":"B38-20250227","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41409-020-01166-w","article-title":"Use of letermovir in off-label indications: infectious diseases working party of European Society of Blood and Marrow Transplantation retrospective study","volume":"56","author":"Styczy\u0144ski","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"8","key":"B39-20250227","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.bbmt.2019.04.022","article-title":"Reduction in nephrotoxic antimicrobial exposure decreases associated acute kidney injury in pediatric hematopoietic stem cell transplant patients","volume":"25","author":"Benoit","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"issue":"5","key":"B40-20250227","doi-asserted-by":"crossref","first-page":"966","DOI":"10.2215\/CJN.08781010","article-title":"Fluid balance, diuretic use, and mortality in acute kidney injury","volume":"6","author":"Grams","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"issue":"6","key":"B41-20250227","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/j.ajkd.2023.04.014","article-title":"Onconephrology: core curriculum 2023","volume":"82","author":"Yarandi","year":"2023","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B42-20250227","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","article-title":"Acute graft-versus-host disease","volume":"9","author":"Malard","year":"2023","journal-title":"Nat Rev Dis Primers."},{"issue":"11","key":"B43-20250227","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT\u2212NIH\u2212CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"B44-20250227","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbmt.2020.09.033","article-title":"Acute graft-versus-host-disease other than typical targets: between myths and facts","volume":"27","author":"Mariotti","year":"2021","journal-title":"Transplant Cell Ther."},{"issue":"12","key":"B45-20250227","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/imj.16188","article-title":"Diagnosis and management of endothelial disorders following haematopoietic stem cell transplantation","volume":"53","author":"McEwan","year":"2023","journal-title":"Intern Med J."},{"issue":"10","key":"B46-20250227","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/s41409-021-01390-y","article-title":"Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation","volume":"56","author":"Luft","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"B47-20250227","first-page":"84","article-title":"Vascular endothelium: checkpoint for inflammation and immunity","volume":"16","author":"Biedermann","year":"2001","journal-title":"News Physiol Sci."},{"issue":"15","key":"B48-20250227","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/bloodadvances.2019000143","article-title":"Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions","volume":"3","author":"Pagliuca","year":"2019","journal-title":"Blood Adv."},{"issue":"4","key":"B49-20250227","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41409-022-01562-4","article-title":"Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy","volume":"57","author":"Feng","year":"2022","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"B50-20250227","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/jcm7110418","article-title":"Systemic capillary leak syndrome (Clarkson syndrome) in cancer patients: a systematic review","volume":"7","author":"Shin","year":"2018","journal-title":"J Clin Med."},{"issue":"4","key":"B51-20250227","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.hemonc.2018.07.004","article-title":"Kidney dysfunction after hematopoietic cell transplantation\u2014etiology, management, and perspectives","volume":"11","author":"Jagu\u015b","year":"2018","journal-title":"Hematol Oncol Stem Cell Ther."},{"issue":"4","key":"B52-20250227","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/bmt.2014.296","article-title":"Engraftment syndrome: double-edged sword of hematopoietic cell transplants","volume":"50","author":"Spitzer","year":"2015","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"B53-20250227","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajh.22202","article-title":"Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis","volume":"87","author":"Irazabal","year":"2012","journal-title":"Am J Hematol."},{"issue":"9","key":"B54-20250227","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/bmt.2009.363","article-title":"Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center","volume":"45","author":"Carreras","year":"2010","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"B55-20250227","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/petr.12652","article-title":"Favorable outcome to glucocorticoid therapy for engraftment syndrome in pediatric autologous hematopoietic cell transplant","volume":"20","author":"Abongwa","year":"2016","journal-title":"Pediatr Transplant."},{"issue":"4","key":"B56-20250227","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/petr.12708","article-title":"Evaluation of engraftment syndrome in children following full-matched related donor hematopoietic stem cell transplantations","volume":"20","author":"\u0130leri","year":"2016","journal-title":"Pediatr Transplant."},{"issue":"6","key":"B57-20250227","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbmt.2014.03.003","article-title":"Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning","volume":"20","author":"Raj","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"issue":"8","key":"B58-20250227","doi-asserted-by":"crossref","first-page":"515.e1","DOI":"10.1016\/j.jtct.2023.05.008","article-title":"Tocilizumab for cytokine release syndrome management after haploidentical hematopoietic cell transplantation with post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"29","author":"Yao","year":"2023","journal-title":"Transplant Cell Ther."},{"issue":"2","key":"B59-20250227","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"issue":"6","key":"B60-20250227","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.jtct.2024.03.026","article-title":"Evaluation of circulating endothelial cells as direct marker of endothelial damage in allo-transplant recipients at high risk of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"30","author":"Farina","year":"2024","journal-title":"Transplant Cell Ther."},{"issue":"7","key":"B61-20250227","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/bmt.2016.130","article-title":"Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation","volume":"51","author":"Mohty","year":"2016","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"B62-20250227","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ki.1994.417","article-title":"Acute renal failure in the setting of bone marrow transplantation","volume":"46","author":"Zager","year":"1994","journal-title":"Kidney Int."},{"issue":"7","key":"B63-20250227","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41409-023-01992-8","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European Society for Blood and Marrow Transplantation (EBMT)","volume":"58","author":"Mohty","year":"2023","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"B64-20250227","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.bbmt.2019.02.018","article-title":"Risk factors for development of and progression of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"25","author":"Corbacioglu","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"issue":"5","key":"B65-20250227","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1182\/bloodadvances.2023011233","article-title":"Incidence and risk factors of early onset VOD\/SOS differ in younger vs older adults after stem cell transplantation","volume":"8","author":"Marcoux","year":"2024","journal-title":"Blood Adv."},{"issue":"6","key":"B66-20250227","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/bmt.2015.52","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives - a position statement from the European Society for Blood and Marrow Transplantation (EBMT)","volume":"50","author":"Mohty","year":"2015","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"B67-20250227","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1705297","article-title":"Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"37","author":"Imran","year":"2006","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"B68-20250227","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial [see comments]","volume":"79","author":"Attal","year":"1992","journal-title":"Blood."},{"issue":"7","key":"B69-20250227","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00007890-199604150-00014","article-title":"Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients","volume":"61","author":"Or","year":"1996","journal-title":"Transplantation."},{"issue":"6","key":"B70-20250227","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood."},{"issue":"3","key":"B71-20250227","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41409-019-0705-z","article-title":"Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a position statement from an international expert group","volume":"55","author":"Mohty","year":"2020","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"B72-20250227","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/S2352-3026(23)00011-X","article-title":"Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial","volume":"10","author":"Grupp","year":"2023","journal-title":"Lancet Haematol."},{"issue":"4","key":"B73-20250227","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjh.13215","article-title":"How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation","volume":"168","author":"Carreras","year":"2015","journal-title":"Br J Haematol."},{"issue":"11","key":"B74-20250227","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.bbmt.2020.08.006","article-title":"Transjugular intrahepatic portosystemic shunt for very severe veno-occlusive disease\/sinusoidal obstruction syndrome (VOD\/SOS) after unmanipulated haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide","volume":"26","author":"G\u00f3mez-Centuri\u00f3n","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"issue":"2","key":"B75-20250227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/petr.13139","article-title":"The role of continuous renal replacement therapy in the management of acute kidney injury associated with sinusoidal obstruction syndrome following hematopoietic cell transplantation","volume":"22","author":"Raina","year":"2018","journal-title":"Pediatr Transplant."},{"issue":"1-3","key":"B76-20250227","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000334149","article-title":"The challenges of providing renal replacement therapy in decompensated liver cirrhosis","volume":"33","author":"Gonwa","year":"2012","journal-title":"Blood Purif."},{"issue":"6","key":"B77-20250227","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MCC.0000000000000657","article-title":"Acute kidney injury in hematopoietic stem cell transplantation","volume":"25","author":"Wanchoo","year":"2019","journal-title":"Curr Opin Crit Care."},{"issue":"2","key":"B79-20250227","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma","volume":"44","author":"George","year":"2004","journal-title":"Transfusion."},{"issue":"4","key":"B80-20250227","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood."},{"issue":"8","key":"B81-20250227","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41409-021-01283-0","article-title":"Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis","volume":"56","author":"Young","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"B82-20250227","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtct.2022.11.015","article-title":"Harmonizing definitions for diagnostic criteria and prognostic assessment of transplantation-associated thrombotic microangiopathy: a report on behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research","volume":"29","author":"Schoettler","year":"2023","journal-title":"Transplant Cell Ther."},{"issue":"6","key":"B83-20250227","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2018.06.013","article-title":"Emerging concepts in hematopoietic stem cell transplantation\u2013associated renal thrombotic microangiopathy and prospects for new treatments","volume":"72","author":"Wanchoo","year":"2018","journal-title":"Am J Kidney Dis."},{"issue":"10","key":"B84-20250227","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/bmt.2017.119","article-title":"Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GVHD","volume":"52","author":"Zeisbrich","year":"2017","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"B85-20250227","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"issue":"9","key":"B86-20250227","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1440-1827.2011.02704.x","article-title":"Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"61","author":"Mii","year":"2011","journal-title":"Pathol Int."},{"issue":"2","key":"B87-20250227","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.beha.2008.02.002","article-title":"Vascular endothelium as \u201cnovel\u201d target of graft-versus-host disease","volume":"21","author":"Tichelli","year":"2008","journal-title":"Best Pract Res Clin Haematol."},{"issue":"1","key":"B88-20250227","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1272\/jnms.JNMS.2020_87-102","article-title":"Renal complications after hematopoietic stem cell transplantation: role of graft-versus-host disease in renal thrombotic microangiopathy","volume":"87","author":"Mii","year":"2020","journal-title":"J Nippon Med Sch."},{"issue":"6","key":"B89-20250227","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","article-title":"Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system","volume":"118","author":"Luft","year":"2011","journal-title":"Blood."},{"issue":"5","key":"B90-20250227","doi-asserted-by":"crossref","first-page":"266.e1","DOI":"10.1016\/j.jtct.2022.01.009","article-title":"Incidence and risk factors of transplantation-associated thrombotic microangiopathy: a systematic review and meta-analysis","volume":"28","author":"Van Benschoten","year":"2022","journal-title":"Transplant Cell Ther."},{"issue":"8","key":"B91-20250227","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood."},{"key":"B92-20250227","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/JBM.S102235","article-title":"Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment","volume":"7","author":"Rosenthal","year":"2016","journal-title":"J Blood Med."},{"issue":"2","key":"B93-20250227","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/bmt.2017.207","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies","volume":"53","author":"Khosla","year":"2018","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"B94-20250227","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/bmt.2008.25","article-title":"Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura","volume":"41","author":"Carella","year":"2008","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"B95-20250227","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06588.x","article-title":"Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab","volume":"137","author":"Au","year":"2007","journal-title":"Br J Haematol."},{"issue":"6","key":"B96-20250227","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transplant."},{"issue":"suppl 4","key":"B97-20250227","first-page":"S57","article-title":"Reeling in complement in transplant-associated thrombotic microangiopathy: you\u2019re going to need a bigger boat","volume":"98","author":"Jodele","year":"2023","journal-title":"Am J Hematol."},{"issue":"9","key":"B98-20250227","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/TP.0000000000000601","article-title":"Use of eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: a study from the SFGM-TC","volume":"99","author":"De Fontbrune","year":"2015","journal-title":"Transplantation."},{"issue":"2","key":"B99-20250227","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1076029615599439","article-title":"Eculizumab in transplant-associated thrombotic microangiopathy","volume":"23","author":"Dhakal","year":"2017","journal-title":"Clin Appl Thromb Hemost."},{"issue":"3","key":"B100-20250227","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/ejh.13127","article-title":"Eculizumab for transplant-associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients","volume":"101","author":"Rudoni","year":"2018","journal-title":"Eur J Haematol."},{"issue":"12","key":"B101-20250227","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood.2023022526","article-title":"A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation\u2013associated TMA","volume":"143","author":"Jodele","year":"2024","journal-title":"Blood."},{"issue":"5","key":"B102-20250227","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1182\/bloodadvances.2021006523","article-title":"Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT","volume":"6","author":"Mizuno","year":"2022","journal-title":"Blood Adv."},{"issue":"22","key":"B103-20250227","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1200\/JCO.21.02389","article-title":"Narsoplimab, a mannan-binding lectin-associated serine protease-2 inhibitor, for the treatment of adult hematopoietic stem-cell transplantation-associated thrombotic microangiopathy","volume":"40","author":"Khaled","year":"2022","journal-title":"J Clin Oncol."},{"issue":"11","key":"B104-20250227","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/bmt.2015.162","article-title":"Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival","volume":"50","author":"Lunde","year":"2015","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"B105-20250227","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00277-016-2725-8","article-title":"A case of BK virus nephropathy without hemorrhagic cystitis after hematopoietic stem cell transplantation","volume":"95","author":"Burbach","year":"2016","journal-title":"Ann Hematol."},{"key":"B106-20250227","doi-asserted-by":"crossref","first-page":"913802","DOI":"10.3389\/fonc.2022.913802","article-title":"Incidence of late-onset hemorrhagic cystitis and its effect on PFS in acute leukemia patients after haplo-PBSCT: the 5-year single-center data","volume":"12","author":"Yuan","year":"2022","journal-title":"Front Oncol."},{"issue":"7","key":"B107-20250227","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3324\/haematol.2009.016758","article-title":"Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type","volume":"95","author":"Silva","year":"2010","journal-title":"Haematologica."},{"issue":"6","key":"B108-20250227","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1053\/j.ajkd.2016.10.007","article-title":"AJKD atlas of renal pathology: polyomavirus nephropathy","volume":"68","author":"Lusco","year":"2016","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"B109-20250227","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/ajt.13635","article-title":"Symptomatic BK virus infection is associated with kidney function decline and poor overall survival in allogeneic hematopoietic stem cell recipients","volume":"16","author":"Abudayyeh","year":"2016","journal-title":"Am J Transplant."},{"issue":"5","key":"B110-20250227","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/TP.0000000000003988","article-title":"Adenovirus infection and transplantation","volume":"106","author":"Al-Heeti","year":"2022","journal-title":"Transplantation."},{"issue":"4","key":"B111-20250227","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbmt.2015.12.009","article-title":"Cidofovir in the treatment of BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Philippe","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"issue":"25","key":"B112-20250227","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2010-04-259291","article-title":"How I treat adenovirus in hematopoietic stem cell transplant recipients","volume":"116","author":"Lindemans","year":"2010","journal-title":"Blood."},{"issue":"1","key":"B113-20250227","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-017-0180-z","article-title":"Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation","volume":"7","author":"Styczynski","year":"2018","journal-title":"Infect Dis Ther."},{"issue":"6","key":"B114-20250227","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.semnephrol.2010.09.008","article-title":"Hematopoietic stem cell transplantation in patients with chronic kidney disease","volume":"30","author":"Heher","year":"2010","journal-title":"Semin Nephrol."},{"issue":"1","key":"B115-20250227","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0609.2005.00446.x","article-title":"Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure","volume":"75","author":"Knudsen","year":"2005","journal-title":"Eur J Haematol."},{"issue":"8","key":"B116-20250227","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/leu.2008.131","article-title":"Pathogenesis and treatment of renal failure in multiple myeloma","volume":"22","author":"Dimopoulos","year":"2008","journal-title":"Leukemia."},{"issue":"6","key":"B117-20250227","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41409-022-01657-y","article-title":"Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option","volume":"57","author":"Lazana","year":"2022","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"B118-20250227","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbmt.2009.03.021","article-title":"Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma","volume":"15","author":"Parikh","year":"2009","journal-title":"Biol Blood Marrow Transplant."},{"issue":"7","key":"B119-20250227","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1681\/ASN.2006020118","article-title":"Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment","volume":"17","author":"Hingorani","year":"2006","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B120-20250227","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ackd.2013.08.007","article-title":"The kidney effects of hematopoietic stem cell transplantation","volume":"21","author":"Sawinski","year":"2014","journal-title":"Adv Chronic Kidney Dis."},{"issue":"5","key":"B121-20250227","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000504354","article-title":"Risk factors for acute kidney injury and chronic kidney disease following allogeneic hematopoietic stem cell transplantation for hematopoietic malignancies","volume":"143","author":"Sakaguchi","year":"2020","journal-title":"Acta Haematol."},{"issue":"6","key":"B122-20250227","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5414\/CN109276","article-title":"Mini-review of kidney disease following hematopoietic stem cell transplant","volume":"89","author":"Sedhom","year":"2018","journal-title":"Clin Nephrol."},{"issue":"5","key":"B123-20250227","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1053\/j.ajkd.2017.02.003","article-title":"AJKD atlas of renal pathology: calcineurin inhibitor nephrotoxicity","volume":"69","author":"Lusco","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"8","key":"B124-20250227","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/ndt\/gfl219","article-title":"Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?","volume":"21","author":"Chapman","year":"2006","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"B125-20250227","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1705454","article-title":"Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease","volume":"38","author":"Wolff","year":"2006","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"B126-20250227","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.bbmt.2015.12.014","article-title":"Adult nephrotic syndrome after hematopoietic stem cell transplantation: renal pathology is the best predictor of response to therapy","volume":"22","author":"Beyar-Katz","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"issue":"6","key":"B127-20250227","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.ajkd.2014.09.001","article-title":"Membranous nephropathy as a manifestation of graft-versus-host disease: association with HLA antigen typing, phospholipase A2 receptor, and C4d","volume":"64","author":"Byrne-Dugan","year":"2014","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"B128-20250227","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.ekir.2024.02.135","article-title":"WCN24-559 protocadherin FAT1-POSITIVE membranous nephropathy secondary to hematopoietic stem-cell transplantation sucessfully treated with rituximab","volume":"9","author":"Ferreira","year":"2024","journal-title":"Kidney Int Rep."},{"issue":"5","key":"B129-20250227","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1681\/ASN.2021111488","article-title":"Hematopoietic stem cell transplant-membranous nephropathy is associated with protocadherin FAT1","volume":"33","author":"Sethi","year":"2022","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B130-20250227","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1053\/j.ajkd.2017.05.002","article-title":"AJKD atlas of renal pathology: chronic interstitial nephritis","volume":"70","author":"Fogo","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"B131-20250227","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000486359","article-title":"Plasma cell disorders and dialysis-dependent renal failure: safety and efficacy of autologous stem cell transplantation","volume":"139","author":"Martini","year":"2018","journal-title":"Acta Haematol."},{"issue":"2","key":"B132-20250227","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1016\/j.bbmt.2013.12.422","article-title":"Nonmyeloablative allogeneic hematopoietic stem cell transplant in patients with end stage renal disease requiring dialysis \u2013 a single institution experience","volume":"20","author":"Shadman","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"issue":"8","key":"B133-20250227","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clml.2015.03.003","article-title":"Autologous hematopoietic stem cell transplantation in dialysis-dependent myeloma patients","volume":"15","author":"El Fakih","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk."},{"issue":"2","key":"B134-20250227","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ajkd.2021.01.015","article-title":"Posttransplant lymphoproliferative disorder following kidney transplantation: a review","volume":"78","author":"Sprangers","year":"2021","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B135-20250227","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbmt.2019.08.021","article-title":"Hematopoietic stem cell transplantation in solid organ recipients with emphasis on transplant complications: a nationwide retrospective survey on behalf of the Japan Society for Hematopoietic Stem Cell Transplantation Transplant Complications Working Group","volume":"26","author":"Shinohara","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"issue":"3","key":"B136-20250227","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/ajt.13017","article-title":"Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT","volume":"15","author":"Basak","year":"2015","journal-title":"Am J Transplant."},{"issue":"2","key":"B137-20250227","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41409-018-0255-9","article-title":"Solid organ transplantation following allogeneic haematopoietic cell transplantation: experience from a referral organ transplantation center and systematic review of literature","volume":"54","author":"Brockmann","year":"2019","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"B138-20250227","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ekir.2024.01.048","article-title":"Kidney transplantation after allogeneic hematopoietic cell transplantation","volume":"9","author":"Ziliotis","year":"2024","journal-title":"Kidney Int Rep."},{"issue":"4S","key":"B139-20250227","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int."},{"issue":"23","key":"B140-20250227","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1056\/NEJMra1404711","article-title":"Renal complications of hematopoietic-cell transplantation","volume":"374","author":"Hingorani","year":"2016","journal-title":"N Engl J Med."},{"issue":"8","key":"B141-20250227","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/petr.12831","article-title":"Epidemiology, risk factors, and prognosis of capillary leak syndrome in pediatric recipients of stem cell transplants: a retrospective single-center cohort study","volume":"20","author":"Lucchini","year":"2016","journal-title":"Pediatr Transplant."},{"issue":"2","key":"B142-20250227","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00277-004-0946-8","article-title":"Granulocyte colony-stimulating factor-induced capillary leak syndrome confirmed by extravascular lung water measurements","volume":"84","author":"Deeren","year":"2005","journal-title":"Ann Hematol."},{"issue":"5","key":"B143-20250227","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s002770050288","article-title":"Risk factors for capillary leakage syndrome after bone marrow transplantation","volume":"74","author":"N\u00fcrnberger","year":"1997","journal-title":"Ann Hematol."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:58:58Z","timestamp":1786478338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":141,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000692","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]}}}